ChoiceSpine's Triton sacroiliac joint fixation system received FDA approval, according to an Oct. 5 news release.
The fixation system is used for conditions including degenerative sacroiliitis and sacroiliac joint disruption. It has a 3D-printed screw that's offered in three diameters. The system has ChoiceSpine's proprietary BioBond technology.
"The addition of the Triton screw to our spinal fusion portfolio delivers on ChoiceSpine’s commitment to provide an innovative, superior system to the sacroiliac fixation market," Keith Clements, vice president of sales, said in a news release.